PS PeptideSuppliers.org The peptide supplier database
Peptides · Tuftsin-derived heptapeptide

Selank: a research guide to the peptide built on tuftsin

A synthetic analog of the immune peptide tuftsin with a stabilizing Pro-Gly-Pro tail, studied in Russian laboratories.

Selank cover illustration

Research-use-only guide. It explains what Selank is and how to read supplier documentation. It offers no dosing, administration or health advice. Supplier links are affiliate links; see below.

It starts with an antibody

Selank has an unlikely origin story. In 1970, two American biochemists, Victor Najjar and Kunio Nishioka, were studying why a certain fraction of the blood protein immunoglobulin G made white blood cells more effective at engulfing bacteria. They traced the activity to a tiny piece of the antibody's heavy chain, which an enzyme in the spleen snips out. The fragment was just four amino acids long: threonine, lysine, proline and arginine. They named it tuftsin, after Tufts University where they worked. Tuftsin binds receptors on macrophages and neutrophils, and a large literature grew up around its effects on immune cells.

The problem with a four-residue peptide is that enzymes demolish it in minutes. A group in Moscow, at the same institute that developed Semax, decided to solve that by lengthening tuftsin. They attached a three-residue tail, Pro-Gly-Pro, to the end. The resulting seven-residue peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, is Selank. It weighs about 752 daltons.

Two rows of circles showing tuftsin with four residues above and Selank with the same four residues followed by proline, glycine and proline
Selank is tuftsin (Thr-Lys-Pro-Arg) extended by a Pro-Gly-Pro tail. Illustration by PeptideSuppliers.org.

The research, and its limits

Most of what has been published about Selank comes from Russian laboratories, and the pattern of findings differs from what you might expect of an immune peptide. Animal studies report behavioural effects in anxiety models, and cell and tissue experiments describe changes in the expression of genes related to neurotransmission and to inflammatory signalling. Proposed mechanisms include modulation of the GABA system, effects on the degradation of enkephalins (natural opioid-like peptides) and changes in cytokine balance. Some clinical studies in Russia examined its use in anxiety-related conditions, and a nasal formulation is registered there as a medicine.

Several cautions apply. The mechanisms above are hypotheses from animal and cell work, not established facts about how the compound behaves in people. The clinical studies tend to be small and many were not blinded. The body of work is concentrated in a few related groups, and independent confirmation is thin. Selank is not approved by the US Food and Drug Administration or by European regulators. This page therefore describes the evidence but draws no conclusions on effects, and we offer no guidance on using it.

What makes it easy and what makes it tricky

Seven residues is well within what any decent peptide laboratory can synthesise cleanly. It contains no cysteine, no tryptophan and no methionine, which are the residues that cause most of the stability and oxidation headaches. Two prolines, one near the middle and a pair at the tail, make the chain stiff but are not hard to couple. In principle, therefore, a good COA for Selank should be unremarkable: one clean peak, a mass of about 752, a respectable purity. That cuts both ways. Because the benchmark is high, a poor-looking trace stands out, and because the molecule is easy, a supplier with weak quality control has fewer excuses.

The residual risks are mundane. Arginine and lysine are strongly basic, so the peptide is sold as a salt, and the counter-ion contributes real weight to the powder. A vial labelled 5 mg might contain noticeably less peptide, depending on whether the salt is acetate or trifluoroacetate. The net peptide content is the number that tells you.

Expected massAbout 752 Da for the free peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro).
Common confusionTuftsin alone (4 residues, about 500 Da) or Semax (about 814 Da). The mass separates them instantly.
ChromatogramFull trace. A single dominant peak is realistic for a seven-residue peptide.
Counter-ionAcetate or trifluoroacetate. Ask which, and whether net content was measured.
VariantsN-acetyl Selank amidate exists as a separate modified product with a different mass.
Batch detailsLot, test date, and laboratory name matching the vial.

Vials versus sprays

As with Semax, Selank is sold in more than one format. The lyophilised vial is the standard research form. A nasal spray, premixed in solution, is a different product with its own quality questions: the concentration, the buffer, preservatives, microbial control and how long the solution stays stable. A COA for the powder says nothing about any of those. If a listing offers both, make sure you know which you are comparing, and treat per-milligram price comparisons between a spray and a vial as meaningless. One of the suppliers below sells a spray alongside the vial.

Why an immune fragment ends up in a neuroscience paper

It can seem strange that a peptide born from immunology is mostly studied for its effects on the nervous system. The connection is that immune and nervous signalling share many molecules. Cytokines such as interleukin-6 act on the brain, tuftsin-like fragments are found near neural tissue, and the Moscow researchers who built Selank were looking for a stable compound that would bridge the two. Their published experiments measured gene expression in the brain after exposure and reported shifts in genes involved in neurotransmission and inflammation. Those findings are interesting and have been cited many times, but they are measurements of expression in animal tissue, and a change in a messenger RNA is a long way from a change in function. Readers who want to go deeper should look for the original methods sections, and should check for the number of animals, the controls used, and whether results were replicated by someone outside the originating laboratory.

The practical lesson for a buyer is simple: the biology is an open question, so the one thing you can actually control is the material. Documentation that proves what is in the vial is worth more than any claim about what it might do.

How it differs from Semax

People often lump the two together, partly because the same institute created them and partly because they share the Pro-Gly-Pro tail. In every other respect, they differ. Semax derives from ACTH and Selank from tuftsin; one is aimed at the nervous system by design, the other began as an immune peptide. A paper about one tells you nothing dependable about the other, and a vendor who uses the words interchangeably is not a vendor to trust on detail. If the question is which of the two to read about first, start with whichever matches what you are actually trying to learn about, and read the primary papers rather than the marketing.

Where to find it

Three suppliers in our directory list Selank. I have not ordered from any for this page; the notes reflect public listings. Check which format each one sells.

Iron Peptides lists Selank as a vial. Code IRONMAN gives 10% off. See our Iron Peptides review; the company is also a sponsored listing on this site.

Next Gen Peps lists Selank in its catalog. See our Next Gen Peps review.

Vortex Research lists Selank as a vial and also as a separate spray product; the link goes to the vial. Its PEPPERS code is advertised at 30% off. It has not been reviewed on this site yet.

All three are affiliate links. PeptideSuppliers.org may earn a commission if you buy, at no extra cost to you. This does not influence our ratings, and the suppliers appear in alphabetical order. Read the disclosure.

Quick answers

Is Selank related to tuftsin?

Yes. It is tuftsin with a stabilising Pro-Gly-Pro tail added to the end.

Is it approved?

It is registered as a medicine in Russia. It has no approval from the FDA or from European regulators.

Why does net peptide content matter?

The counter-ion and residual water can make up a fifth or more of a powder's weight, so a label amount is not the same as peptide amount.

Related: KPV is another short immune-related peptide. To compare all suppliers, see the supplier database.

For laboratory research use only. Not medical advice; no claims about safety, legality or fitness for any use. See the medical disclaimer.